Biotech China 2014

Biology: Memorial Sloan-Kettering Cancer Center

Total Score People Score Events Score
103 79 41
Date Event Presentation Speakers
February 2, 2014 Developmental Pathways and Cancer: Wnt, Notch and Hedgehog (J7) Cancer in Context: The Microenvironment and Metastasis Registered attendees can view abstracts starting on 01/02/2014 Manuel Valiente-Cortes
January 12, 2014 Gordon Research Conference: Glycolipid & Sphingolipid Biology Richard Kolesnick (Sloan-Kettering Cancer Center, USA) "Introduction: Key Issues & Questions" Richard Kolesnick
Translational Studies and Therapeutics: Sphingosine-1-Phosphate Richard Kolesnick
November 21, 2013 Cell Symposia: Using Stem Cells to Model and Treat Human Disease Induced aging for iPSC-based modeling of late-onset disease Lorenz Studer
May 31, 2013 ASCO Annual Meeting 2013 Multimodality Approaches to Achieving Tobacco Cessation in the Oncology Practice Jamie S. Ostroff
Optimizing the Role of Advanced Practice Professionals in Oncology Practice Dean Bajorin
Prostate Cancer Screening: Past, Present, and Future Peter T Scardino, Ethan M. Basch
Relating to Patients on a Humanistic or Spiritual Level: How Physicians Can Make a Difference (M01) Jimmie C Holland
More Mastectomies: Why? (C05) Monica Morrow
Multiplex Genetic Testing for Inherited Cancer Risk: Pros and Cons Mark Robson
Optimizing Locoregional Treatment in Early-Stage Breast Cancer Hiram S. Cody
Education Sessions Robert G Maki, Leonard Saltz
Education Sessions Ethan M. Basch
Education Sessions Kenneth Offit
Education Sessions Andrew David Zelenetz, Stuart M Lichtman, Sergio Giralt
Special Session Teresa Gilewski
April 6, 2013 AACR Annual Meetings CANCER EVOLUTION AND RESISTANCE Neal Rosen
Cross-Species Analysis of Mouse and Human Cancer Chairperson: David J. Adams, Wellcome Trust Sanger Institute, Cambridge, United Kingdom Hans-Guido Wendel
Building on the Success of CTLA-4 Blockade Through Biomarker Analyses and Development of Novel Combinatorial Strategies Chairperson: Jedd D. Wolchok, Memorial Sloan-Kettering Cancer Center, New York, NY Jedd D. Wolchok, Margaret Callahan
Use of Next-Generation Sequencing: Implementation of Clinical Genomics Chairperson: David B. Solit, Memorial Sloan-Kettering Cancer Center, New York, NY David B. Solit
Structural Aberrations in a Thousand Tumors Chairperson: Raju Kucherlapati, Harvard Medical School, Boston, MA Chris Sander
The Molecular Basis for Improvement in Endometrial Cancer Therapy Co-Chairpersons: Cheryl Lyn Walker, Texas A&M University Health Science Center, Houston, TX, and Douglas A. Levine, Memorial Sloan-Kettering Cancer Center, New York, NY Douglas A. Levine
Using Genomics to Guide Cancer Immunotherapy Chairperson: Robert D. Schreiber, Washington University School of Medicine, St. Louis, MO James P Allison
Novel Therapeutic Concepts with Kinases, Immuno-, and Radiotherapy Chairperson: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY James A. Fagin
Predictive Modeling of Cancer Treatment in Single Patients (N of 1) Moderator: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY David B. Solit
Clinical Trials Based on Mutations versus Histology Charles L Sawyers
Credentialing Response Biomarkers for Signal Transduction Inhibitors Chairperson: Neal Rosen, Memorial Sloan-Kettering Cancer Center, New York, NY Neal Rosen
Noncoding RNAs in Cancer: From Pathogenesis to Therapeutics Chairperson: Elsa R. Flores, The University of Texas MD Anderson Cancer Center, Houston, TX Andrea Ventura
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY David C Lyden
Progress in Targeting Chromatin Modifying Enzymes in Cancer Therapy Victoria M. Richon, Sanofi Oncology, Cambridge, MA Victoria M. Richon
Macrophages as a Therapeutic Target in the Tumor Microenvironment Johanna A. Joyce, Memorial Sloan-Kettering Cancer Center, New York, NY Johanna A. Joyce
January 20, 2013 Tumor Invasion and Metastasis Macrophages as a therapeutic target in invasive gliomas Johanna A Joyce
Niches and pathways of latent and overt metastasis Joan Massagué
Session 4: Metastasis Signaling Pathways Joan Massagué
December 4, 2012 CTRC-AACR San Antonio Breast Cancer Symposium Navigating the Obstacles and Risks of Survivorship – Ballroom A Michael L Krychman
The Practical Use of Molecular Profiling – Ballroom A Clifford Hudis
March 4, 2012 Protein-RNA Interactions in Biology and Disease (C1) Structural Biology of RBPs and RNPs Marianna Teplova
October 20, 2011 Nature Chemical Biology Symposium 2011: Cancer Chemical Biology TBA Neal Rosen
August 21, 2011 The TGF-β Superfamily: Signaling in Development and Disease A Smad epigenetic switch in stem cell regulation Joan Massagué
Session 9 | TGFβ signaling and Stem cell regulation Joan Massagué
May 26, 2011 Idibell Cancer Conference on Metastasis and Angiogenesis The tumor microenvironment in cancer progression and response to therapy Johanna A Joyce
May 18, 2011 SBI 10th Postgraduate Course High Risk Screening D. David Dershaw
Challenging Cases MRI (Audience Response System) Christopher E. Comstock
Cancer | The Patient’s Perspective Laura Liberman
Management After MR Biopsy Carol H. Lee
Updates in Imaging | Cases for the Experts D. David Dershaw
March 27, 2011 Methods in Chemical Biology Diversity and Design: New Small Molecule Probes for Biology and Medicine Derek Tan
March 9, 2011 28th Annual Miami Breast Cancer Conferenceâ„¢ Hereditary Breast Cancers Mark Robson
Occult Carcinoma Hiram S. Cody
Predisposition Syndromes Associated With Breast Cancer Mark Robson
How to Do a Sentinel Node Biopsy: Axillary Dissections and Internal Mammary Biopsy Hiram S. Cody
Sessions 3 | "Meet the Professor" Sessions Mark Robson
Session A | Prophylactic Contralateral Mastectomy: Current Recommendations, Technique, and Outcome Hiram S. Cody
February 27, 2011 AACR-NCI Conference on Systems Biology: Confronting the Complexity of Cancer Session 4 | Cancer Stem Cells/Developmental Biology Franziska Michor
February 26, 2011 Mucosal Biology: A Fine Balance between Tolerance and Immunity (X5) Bacterial Flagellin Stimulates TLR5-Dependent Defense Against Vancomycin-Resistant Enterococcus Infection Melissa Kinnebrew
February 17, 2011 15th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma Overall Survival Andrew D. Zelenetz, MD, PhD
Welcome Andrew D. Zelenetz, MD, PhD
Do New Therapies Change the Paradigm for Treatment of Peripheral T-Cell Lymphoma? Steven Horwitz
Comment Steven Horwitz
Myeloproliferative Neoplasms Martin S. Tallman
Can Acute Promyelocytic Leukemia Be Managed Without Chemotherapy? Martin S. Tallman
Afternoon Workshop | Monoclonal Antibodies Andrew D. Zelenetz, MD, PhD
Supportive Care in Hematologic Malignancies Andrew D. Zelenetz, MD, PhD
Lymphoma Steven Horwitz
Chronic Lymphocytic Leukemia Andrew D. Zelenetz, MD, PhD
Tumor Boards | Challenging Cases in Hematologic Malignancies and Attendee-Submitted Cases Andrew David Zelenetz
February 13, 2011 Inositide Signaling in Pharmacology and Disease (X1) PI 3-Kinases (X2) | PI3K Pathways in Cancer, Mechanistic Insights Neal Rosen
December 8, 2010 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium Challenges to clinical application of new discoveries in the genetics of breast cancer predisposition Mark Robson
The Clinical Utility of Genetic Testing for Inherited Predisposition to Breast Cancer: BRCA and Beyond | Ballroom C-2 Mark Robson
November 3, 2010 Eighth Annual RNAi for Functional Screens RNAi, mRNA Biogenesis and Genome-wide Drug Modifier Screens Hakim Djaballah
June 12, 2010 Genetics 2010: Model Organisms to Human Biology Session 4: Cancer as a genetic disease Kathryn V. Anderson
May 26, 2010 International Symposium Stem Cells in Biology & Disease SESSION 5: Technological advances in manipulating pluripotent stem cells Lorenz Studer
May 19, 2010 Towards Personalized Cancer Medicine Deconstructing Metastasis Joan Massagué
SESSION I: Biology (Processes Leading to Cancer) Joan Massagué
Closing Remarks Joan Massagué
Immune Checkpoint Blockade in Cancer Therapy James P Allison
April 30, 2010 UCSF Radiation Oncology Update: Management of Recurrent Disease Case Presentations and Panel Discussion Nancy Lee
Local Recurrence in the Nasopharynx and other Non-NP Head and Neck Sites Nancy Lee
HEAD AND NECK TUMORS Nancy Lee
Surgical Salvage for Recurrence after Radiotherapy James Eastham
November 2, 2009 Track 1: Seventh Annual RNAi for Screening Cellular Pathways and Targets Genome-wide siRNA Gain-of-Function Screen for Modulators of the miRNA Pathway Hakim Djaballah
September 19, 2009 Nature Chemical Biology Symposium 2009: Chemical Biology in Drug Discovery Natural product-based libraries for chemical biology and drug discovery Derek Tan
February 28, 2009 Biophysical Society 53rd Annual Meeting Symposium 14: RNA in Biology and Disease Christopher D. Lima, Dinshaw J. Patel
December 7, 2008 AMERICAN SOCIETY FOR MATRIX BIOLOGY 2008 Meeting Concurrent J: Merlin Blocks Tumorigenesis by Inhibiting a Nuclear E3 Ligase Filippo , Giancotti
November 20, 2008 The 13th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology Overcoming Stem Cell Resistance Eric C Holland
June 11, 2008 6th ISSCR Annual Meeting Session III C: Cell Cycle Regulation & Signaling Kathryn V. Anderson
CILIA AND DEVELOPMENTAL SIGNALING Kathryn V. Anderson
May 30, 2008 ASCO Annual'08 Meeting general oncology sessions-- The Growing Challenge of CNS Metastases: New Therapeutic Approaches Lauren E. Abrey
general oncology sessions-- Integrating the Humanistic and Scientific Aspects of Patient Care: The Perspective of Seasoned Surgical, Medical, Pediatric, and Radiation Oncologists Teresa Gilewski
breast cancer-- Chemotherapy-Induced Cognitive Impairment (M06) Tim A Ahles
central nervous system tumors-- Chemotherapy-Induced Cognitive Impairment (M06) Tim A Ahles
central nervous system tumors-- The Growing Challenge of CNS Metastases: New Therapeutic Approaches Lauren E. Abrey
clinical trials-- Patient-Reported Outcomes in Oncology Ethan M. Basch
gynecologic cancer-- Benefit of Multimodality Management of Advanced Sarcoma: Why the Medical Oncologist Should Not Work Alone Murray F. Brennan
head and neck cancer-- Physiologic Response Imaging in Head and Neck Cancer Clifton Ling
health services research-- Patient-Reported Outcomes in Oncology Ethan M. Basch
lymphoma and plasma cell disorders-- Prognosis, Risk Stratification, and Treatment of Diffuse Large B-Cell Lymphoma: Incorporation of New Imaging Modalities and Molecular Markers (CPO11A) Andrew David Zelenetz
lymphoma and plasma cell disorders-- Prognosis, Risk Stratification, and Treatment of Diffuse Large B-Cell Lymphoma: Incorporation of New Imaging Modalities and Molecular Markers (CPO11B) Andrew David Zelenetz
patient and survivor care-- Patient-Reported Outcomes in Oncology Ethan M. Basch
patient and survivor care-- Integrating the Humanistic and Scientific Aspects of Patient Care: The Perspective of Seasoned Surgical, Medical, Pediatric, and Radiation Oncologists Teresa Gilewski
professional development-- Integrating the Humanistic and Scientific Aspects of Patient Care: The Perspective of Seasoned Surgical, Medical, Pediatric, and Radiation Oncologists Teresa Gilewski
sarcoma/bone and soft tissue cancers-- Benefit of Multimodality Management of Advanced Sarcoma: Why the Medical Oncologist Should Not Work Alone Murray F. Brennan
tumor biology-- Physiologic Response Imaging in Head and Neck Cancer Clifton Ling
meet the professor sessions-- Chemotherapy-Induced Cognitive Impairment (M06) Tim A Ahles
clinical problems in oncology-- Prognosis, Risk Stratification, and Treatment of Diffuse Large B-Cell Lymphoma: Incorporation of New Imaging Modalities and Molecular Markers (CPO11A) Andrew David Zelenetz
clinical problems in oncology-- Prognosis, Risk Stratification, and Treatment of Diffuse Large B-Cell Lymphoma: Incorporation of New Imaging Modalities and Molecular Markers (CPO11B) Andrew David Zelenetz
March 30, 2008 Nuclear Receptors: Steroid Sisters Steroid Receptors and Cancer Nicola J. Clegg
March 30, 2008 Nuclear Receptors: Orphan Brothers Steroid Receptors and Cancer Nicola J. Clegg
March 25, 2008 RNAi, MicroRNA, and Non-Coding RNA MicroRNAs and Their Targets (Plants and Invertebrates) Eric C Lai
February 17, 2008 GRC - Glycolipid & Sphingolipid Biology Discussion Richard Kolesnick
January 6, 2008 Structural Genomics and its Applications to Chemistry, Biology and Medicine Following Session is for Structural Biology (J1) Macromolecular Interactions Juha P. Himanen
Following Session is for Structural Biology (J1) Protein – Nucleic Acid Interactions Marianna Teplova, Christopher D. Lima
Following Session is for Structural Biology (J1) Large Macromolecular Complexes Christopher D. Lima
January 6, 2008 Frontiers of Structural Biology Macromolecular Interactions Juha P. Himanen
Protein – Nucleic Acid Interactions Marianna Teplova, Christopher D. Lima
Large Macromolecular Complexes Christopher D. Lima
December 1, 2007 47TH American Socieity of Cell Biology Getting In Shape: New Clues From the Fly Embryo Jennifer A Zallen
Interphase and Mitotic CDKs Follow Kinetically Distinct Paths to Activation in Human Cells. S. Larochelle, R P Fisher
The Cell Biology of Embryonic Patterning and Morphogenesis in the Mouse Embryo Kathryn V. Anderson, Josh Bloomekatz, Isabelle Migeotte
Binding of the HBV X Protein to hBubR1 Disturbs the Mitotic Checkpoint and Increases Chromosome Instability Jeff Lee
Polarized Cell Behavior during Axis Elongation in Drosophila. Jennifer A Zallen, J Blankenship, J S P. Sanny, O Weitz
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 6: New & Emerging Biomarkers & Drug Targets (09:00-12:00) Anh Tuan Phan
Session 6: G-quadruplex Structures of Nucleic Acids as Potential Targets for Drug Design (11:00-11:20) Anh Tuan Phan
October 16, 2007 Inaugural HDAC inhibitors: Meeting the Challenges of Chemical Development of HDAC Inhibitors Oct (16 -17) OVERCOMING THE CHALLENGES: ADVANCED HDAC INHIBITORS (08:30-11:10) Paul A. Marks
OVERCOMING THE CHALLENGES - ADVANCED HDAC INHIBITORS: Chairperson’s Remarks (08:30-08:40) Paul A. Marks
MOLECULAR MODE-OF-ACTION AND BIOMARKER STRATEGIES FOR CLINICAL DEVELOPMENT: Histone Deacetylase Inhibitors: Molecular Mechanism of Action (11:10-11:40) Paul A. Marks
MOLECULAR MODE-OF-ACTION AND BIOMARKER STRATEGIES FOR CLINICAL DEVELOPMENT(11:10-16:30) Howard Scher, Paul A. Marks
MOLECULAR MODE-OF-ACTION AND BIOMARKER STRATEGIES FOR CLINICAL DEVELOPMENT: Panel Discussion- Are HDAC Inhibitors Proving Their Worth in the Clinic? (14:25-15:25) Howard Scher, Paul A. Marks
MOLECULAR MODE-OF-ACTION AND BIOMARKER STRATEGIES FOR CLINICAL DEVELOPMENT: Panel Chairperson’s Remarks (13:10-14:20) Paul A. Marks
September 7, 2007 The 2007 Breast Symposium Non-Oncologic Consequences of Estrogen Depletion Michael L Krychman
Oral Abstract Presentation Session A 10:30 AM — 12:00 PM Larry Norton
General Session VI: HER2 Positive Breast Cancer 10:00 AM — 11:45 AM Clifford A. Hudis
Imaging and HER2 Therapy: Targeting and Response Steven M. Larson
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.